Triptorelin for Ovary Protection in Childhood Onset Lupus
Latest Information Update: 06 Jan 2021
At a glance
- Drugs Triptorelin (Primary)
- Indications Ovarian disorders
- Focus Adverse reactions; Therapeutic Use
- 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 25 Aug 2011 Planned end date changed from 1 Sep 2008 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 25 Aug 2011 Planned end date changed from 1 Sep 2008 to 1 Sep 2013 as reported by ClinicalTrials.gov.